サマリー

アジア太平洋地域の採血市場に関する調査レポート 2030年までの予測

市場概要
APAC採血市場の成長は、貧血やその他の血液疾患の有病率の高さ、事故や外傷の症例数の増加、診断処置の需要の高まりに起因している。しかし、採血中の傷害や政府の厳しい政策が市場成長を阻害している。それにもかかわらず、政府のイニシアチブの高まりがAPAC採血市場に有利な機会を生み出していると予想される。
APAC採血市場の成長が期待される背景には、貧血やその他の血液疾患の有病率の高さ、事故や外傷の症例数の増加、診断処置に対する需要の高まりがある。しかし、採血中の怪我や政府の厳しい政策も市場の足かせとなっている。とはいえ、政府のイニシアチブの高まりは、APAC採血市場で活動するプレーヤーに有利な機会を創出すると予想される。
市場区分
用途に基づき、アジア太平洋地域の採血市場は診断と治療に区分される。診断分野は2022年に市場を支配し、予測期間である2023-2030年に最も急成長する分野と予測されている。
アジア太平洋地域の採血市場は、方法に基づいて、手動採血と自動採血にセグメント化されている。エンドユーザーに基づくと、アジア太平洋地域の採血市場は診断＆病理検査室、病院＆クリニック、血液銀行、その他に区分される。アジア太平洋地域の採血市場は、インド、日本、シンガポール、マレーシア、韓国、オーストラリア＆ニュージーランド、その他のアジア太平洋地域で構成されている。
主要プレイヤー
Fresenius Kabi AG（ドイツ） Medtronic Plc（アイルランド）、Becton, Dickinson, and Company（米国）、Quest Diagnostics Incorporated（米国）、Grifols S.A.（スペイン）、Kawasumi Laboratories America（米国）、ニプロメディカル株式会社（日本）、テルモメディカル株式会社（日本）、ICU Medical, Inc（米国）、Haemonetics Corporation（米国）。

ページTOPに戻る

目次

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY 13
1.1 OVERVIEW 13
2 MARKET INTRODUCTION 14
2.1 DEFINITION 14
2.2 SCOPE OF THE STUDY 14
2.3 RESEARCH OBJECTIVE 14
2.4 MARKET STRUCTURE 15
2.5 ASSUMPTIONS & LIMITATIONS 16
3 RESEARCH METHODOLOGY 17
3.1 DATA MINING 17
3.2 SECONDARY RESEARCH 18
3.3 PRIMARY RESEARCH 19
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 20
3.5 FORECASTING TECHNIQUES 21
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 22
3.6.1 BOTTOM-UP APPROACH 23
3.6.2 TOP-DOWN APPROACH 23
3.7 DATA TRIANGULATION 24
3.8 VALIDATION 24
4 MARKET DYNAMICS 25
4.1 OVERVIEW 25
4.2 DRIVERS 26
4.2.1 HIGH PREVALENCE OF ANEMIA AND OTHER BLOOD DISORDERS 26
4.2.2 GROWING NUMBER OF ACCIDENTS & TRAUMA CASES 26
4.2.3 RISING DEMAND FOR DIAGNOSTIC PROCEDURES 26
4.3 RESTRAINTS 27
4.3.1 INJURY CAUSED DURING BLOOD COLLECTION 27
4.3.2 STRINGENT GOVERNMENT POLICIES 28
4.4 OPPORTUNITIES 29
4.4.1 GROWING GOVERNMENT INITIATIVES 29
5 MARKET FACTOR ANALYSIS 30
5.1 VALUE CHAIN ANALYSIS 30
5.1.1 R&D & DESIGNING 30
5.1.2 MANUFACTURING 31
5.1.3 DISTRIBUTION & SALES 31
5.1.4 POST-SALES MONITORING 31
5.2 PORTER'S FIVE FORCES MODEL 32
5.2.1 THREAT OF NEW ENTRANTS 32
5.2.2 BARGAINING POWER OF SUPPLIERS 33
5.2.3 THREAT OF SUBSTITUTES 33
5.2.4 BARGAINING POWER OF BUYERS 33
5.2.5 INTENSITY OF RIVALRY 33
5.3 IMPACT OF COVID-19 ON THE APAC BLOOD COLLECTION MARKET 34
5.3.1 IMPACT ON MAKET GROWTH 34
5.3.2 IMPACT ON SUPPLY CHAIN 34
5.3.3 IMPACT ON PRODUCTION 34
6 ASIA-PACIFIC BLOOD COLLECTION MARKET, BY PRODUCT 35
6.1 OVERVIEW 35
6.2 BLOOD COLLECTION TUBES 37
6.2.1 BY FORM 38
6.2.1.1 VACUUM 38
6.2.1.2 NON-VACUUM 39
6.2.2 BY TYPE 39
6.2.2.1 SERUM-SEPARATING TUBES 40
6.2.2.2 EDTA TUBES 40
6.2.2.3 HEPARIN TUBES 41
6.2.2.4 GLUCOSE TUBES 41
6.2.2.5 PLASMA-SEPARATING TUBES 42
6.2.2.6 OTHERS 42
6.3 NEEDLES & SYRINGES 43
6.4 BLOOD BAGS 43
6.5 BLOOD COLLECTION DEVICES 44
6.6 LANCETS 44
6.7 OTHERS 45
7 ASIA-PACIFIC BLOOD COLLECTION MARKET, BY METHOD 46
7.1 OVERVIEW 46
7.2 MANUAL BLOOD COLLECTION 48
7.3 AUTOMATED BLOOD COLLECTION 48
 
8 ASIA-PACIFIC BLOOD COLLECTION MARKET, BY APPLICATION 49
8.1 OVERVIEW 49
8.2 DIAGNOSTICS 50
8.3 TREATMENTS 51
9 ASIA-PACIFIC BLOOD COLLECTION MARKET, BY END USER 52
9.1 OVERVIEW 52
9.2 DIAGNOSTIC & PATHOLOGY LABORATORIES 54
9.3 HOSPITALS & CLINICS 55
9.4 BLOOD BANKS 55
9.5 OTHERS 56
10 ASIA-PACIFIC BLOOD COLLECTION MARKET, BY COUNTRY 57
10.1 OVERVIEW 57
10.2 INDIA 62
10.3 JAPAN 64
10.4 SINGAPORE 66
10.5 MALAYSIA 68
10.6 SOUTH KOREA 70
10.7 AUSTRALIA & NEW ZEALAND 72
10.8 REST OF ASIA-PACIFIC 75
11 COMPETITIVE LANDSCAPE 78
11.1 OVERVIEW 78
11.2 COMPETITIVE BENCHMARKING 79
11.3 MAJOR GROWTH STRATEGY IN THE ASIA-PACIFIC BLOOD COLLECTION MARKET 80
11.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE ASIA-PACIFIC BLOOD COLLECTION MARKET 80
11.5 KEY DEVELOPMENTS & GROWTH STRATEGIES 81
11.5.1 EXPANSION 81
11.6 FINANCIAL MATRIX 82
11.6.1 SALES (USD MILLION), 2022 82
11.6.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2022 82
12 COMPANY PROFILES 83
12.1 QUEST DIAGNOSTICS INCORPORATED 83
12.1.1 COMPANY OVERVIEW 83
12.1.2 FINANCIAL OVERVIEW 84
12.1.3 PRODUCTS OFFERED 84
12.1.4 KEY DEVELOPMENTS 85
12.1.5 SWOT ANALYSIS 85
12.1.6 KEY STRATEGIES 86
12.2 ICU MEDICAL 87
12.2.1 COMPANY OVERVIEW 87
12.2.2 FINANCIAL OVERVIEW 88
12.2.3 PRODUCTS OFFERED 89
12.2.4 KEY DEVELOPMENTS 89
12.2.5 SWOT ANALYSIS 90
12.2.6 KEY STRATEGIES 90
12.3 KAWASUMI LABORATORIES AMERICA 91
12.3.1 COMPANY OVERVIEWS 91
12.3.2 FINANCIAL OVERVIEW 91
12.3.3 PRODUCTS OFFERED 91
12.3.4 KEY DEVELOPMENTS 91
12.3.5 KEY STRATEGIES 91
12.4 HAEMONETICS CORPORATION 92
12.4.1 COMPANY OVERVIEW 92
12.4.2 FINANCIAL OVERVIEW 93
12.4.3 PRODUCTS OFFERED 93
12.4.4 KEY DEVELOPMENTS 94
12.4.5 KEY STRATEGIES 94
12.5 NIPRO MEDICAL CORPORATION 95
12.5.1 COMPANY OVERVIEW 95
12.5.2 FINANCIAL OVERVIEW 95
12.5.3 PRODUCTS OFFERED 95
12.5.4 KEY DEVELOPMENTS 96
12.5.5 KEY STRATEGIES 96
12.6 BECTON, DICKINSON, AND COMPANY 97
12.6.1 COMPANY OVERVIEW 97
12.6.2 FINANCIAL OVERVIEW 98
12.6.3 PRODUCTS OFFERED 99
12.6.4 KEY DEVELOPMENTS 99
12.6.5 SWOT ANALYSIS 99
12.6.6 KEY STRATEGIES 100
12.7 MEDTRONIC PLC 101
12.7.1 COMPANY OVERVIEW 101
12.7.2 MEDTRONIC PLC: FINANCIAL OVERVIEW SNAPSHOT 102
12.7.3 MEDTRONIC PLC: PRODUCTS OFFERED 103
12.7.4 KEY DEVELOPMENTS 103
12.7.5 SWOT ANALYSIS 104
12.7.6 KEY STRATEGIES 104
12.8 TERUMO MEDICAL CORPORATION 105
12.8.1 COMPANY OVERVIEW 105
12.8.2 FINANCIAL OVERVIEW 106
12.8.3 PRODUCTS OFFERED 106
12.8.4 KEY DEVELOPMENTS 107
12.8.5 SWOT ANALYSIS 107
12.8.6 KEY STRATEGIES 107
12.9 FRESENIUS KABI AG 108
12.9.1 COMPANY OVERVIEW 108
12.9.2 PRODUCTS OFFERED 109
12.9.3 KEY DEVELOPMENTS 109
12.9.4 KEY STRATEGIES 109
12.10 GRIFOLS S.A 110
12.10.1 COMPANY OVERVIEW 110
12.10.2 FINANCIAL OVERVIEW 110
12.10.3 PRODUCTS OFFERED 111
12.10.4 KEY DEVELOPMENTS 111
12.10.5 KEY STRATEGIES 111
13 APPENDIX 112
13.1 REFERENCES 112
13.2 ASSOCIATION OF INDIAN MEDICAL DEVICE INDUSTRY (AIMED) 112
13.3 INTERNATIONAL SOCIETY OF BLOOD TRANSFUSION (ISBT) 112
13.4 INDIAN RED CROSS SOCIETY 112
13.5 NATIONAL BLOOD TRANSFUSION COUNCIL (NBTC) 112
13.6 THE JAPANESE RED CROSS SOCIETY (JRCS) 112
13.7 SINGAPORE RED CROSS SOCIETY 112
13.8 ASSOCIATION OF MALAYSIAN MEDICAL INDUSTRIES (AMMI) 112
13.9 MEDICAL TECHNOLOGY ASSOCIATION OF AUSTRALIA (MTAA) 112
13.10 NEW ZEALAND BLOOD SERVICE (NZBS) 112
13.11 JAPAN BLOOD PRODUCTS ORGANIZATION 112
13.12 RELATED REPORTS 113
 

ページTOPに戻る

図表リスト

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 16
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19
TABLE 3 ASIA-PACIFIC BLOOD COLLECTION MARKET, BY PROD UCT, 2019–2030 (USD MILLION) 36
TABLE 4 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY COUNTRY, 2019–2030 (USD MILLION) 37
TABLE 5 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY FORM, 2019–2030 (USD MILLION) 38
TABLE 6 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR VACUUM, BY COUNTRY, 2019–2030 (USD MILLION) 38
TABLE 7 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR NON-VACUUM, BY COUNTRY, 2019–2030 (USD MILLION) 39
TABLE 8 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY TYPE, 2019–2030 (USD MILLION) 39
TABLE 9 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR SERUM-SEPARATING TUBES, BY COUNTRY, 2019–2030 (USD MILLION) 40
TABLE 10 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR EDTA TUBES, BY COUNTRY, 2019–2030 (USD MILLION) 40
TABLE 11 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR HEPARIN TUBES, BY COUNTRY, 2019–2030 (USD MILLION) 41
TABLE 12 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR GLUCOSE TUBES, BY COUNTRY, 2019–2030 (USD MILLION) 41
TABLE 13 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR PLASMA-SEPARATING TUBES, BY COUNTRY, 2019–2030 (USD MILLION) 42
TABLE 14 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR OTHERS, BY COUNTRY, 2019–2030 (USD MILLION) 42
TABLE 15 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR NEEDLES & SYRINGES, BY COUNTRY, 2019–2030 (USD MILLION) 43
TABLE 16 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR BLOOD BAGS, BY COUNTRY, 2019–2030 (USD MILLION) 43
TABLE 17 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION DEVICES, BY COUNTRY, 2019–2030 (USD MILLION) 44
TABLE 18 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR LANCETS, BY COUNTRY, 2019–2030 (USD MILLION) 44
TABLE 19 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR OTHERS, BY COUNTRY, 2019–2030 (USD MILLION) 45
TABLE 20 ASIA-PACIFIC BLOOD COLLECTION MARKET, BY METHOD, 2019–2030 (USD MILLION) 47
TABLE 21 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR MANUAL BLOOD COLLECTION, BY COUNTRY, 2019–2030 (USD MILLION) 48
TABLE 22 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR AUTOMATED BLOOD COLLECTION, BY COUNTRY, 2019–2030 (USD MILLION) 48
TABLE 23 ASIA-PACIFIC BLOOD COLLECTION MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 50
TABLE 24 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR DIAGNOSTICS, BY COUNTRY, 2019–2030 (USD MILLION) 50
TABLE 25 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR TREATMENTS, BY COUNTRY, 2019–2030 (USD MILLION) 51
TABLE 26 ASIA-PACIFIC BLOOD COLLECTION MARKET, BY END USER 2019–2030 (USD MILLION) 53
TABLE 27 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR DIAGNOSTIC & PATHOLOGY LABORATORIES, BY COUNTRY,
2019–2030 (USD MILLION) 54
TABLE 28 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR HOSPITALS & CLINICS, BY COUNTRY, 2019–2030 (USD MILLION) 55
TABLE 29 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR BLOOD BANKS, BY COUNTRY, 2019–2030 (USD MILLION) 55
TABLE 30 ASIA-PACIFIC BLOOD COLLECTION MARKET, FOR OTHERS, BY COUNTRY, 2019–2030 (USD MILLION) 56
TABLE 31 ASIA-PACIFIC: BLOOD COLLECTION MARKET, BY COUNTRY, 2019–2030 (USD MILLION) 59
TABLE 32 ASIA-PACIFIC: BLOOD COLLECTION MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 60
TABLE 33 ASIA-PACIFIC: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY FORM, 2019–2030 (USD MILLION) 60
TABLE 34 ASIA-PACIFIC: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY TYPE, 2019–2030 (USD MILLION) 61
TABLE 35 ASIA-PACIFIC: BLOOD COLLECTION MARKET, BY METHOD, 2019–2030 (USD MILLION) 61
TABLE 36 ASIA-PACIFIC: BLOOD COLLECTION MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 61
TABLE 37 ASIA-PACIFIC: BLOOD COLLECTION MARKET, BY END USER, 2019–2030 (USD MILLION) 62
TABLE 38 INDIA: BLOOD COLLECTION MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 62
TABLE 39 INDIA: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY FORM, 2019–2030 (USD MILLION) 62
TABLE 40 INDIA: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY TYPE, 2019–2030 (USD MILLION) 63
TABLE 41 INDIA: BLOOD COLLECTION MARKET, BY METHOD, 2019–2030 (USD MILLION) 63
TABLE 42 INDIA: BLOOD COLLECTION MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 63
TABLE 43 INDIA: BLOOD COLLECTION MARKET, BY END USER, 2019–2030 (USD MILLION) 64
TABLE 44 JAPAN: BLOOD COLLECTION MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 64
TABLE 45 JAPAN: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY FORM, 2019–2030 (USD MILLION) 64
TABLE 46 JAPAN: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY TYPE, 2019–2030 (USD MILLION) 65
TABLE 47 JAPAN: BLOOD COLLECTION MARKET, BY METHOD, 2019–2030 (USD MILLION) 65
TABLE 48 JAPAN: BLOOD COLLECTION MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 65
TABLE 49 JAPAN: BLOOD COLLECTION MARKET, BY END USER, 2019–2030 (USD MILLION) 66
TABLE 50 SINGAPORE: BLOOD COLLECTION MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 66
TABLE 51 SINGAPORE: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY FORM, 2019–2030 (USD MILLION) 66
TABLE 52 SINGAPORE: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY TYPE, 2019–2030 (USD MILLION) 67
TABLE 53 SINGAPORE: BLOOD COLLECTION MARKET, BY METHOD, 2019–2030 (USD MILLION) 67
TABLE 54 SINGAPORE: BLOOD COLLECTION MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 67
TABLE 55 SINGAPORE: BLOOD COLLECTION MARKET, BY END USER, 2019–2030 (USD MILLION) 68
TABLE 56 MALAYSIA: BLOOD COLLECTION MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 68
TABLE 57 MALAYSIA: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY FORM, 2019–2030 (USD MILLION) 68
TABLE 58 MALAYSIA: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY TYPE, 2019–2030 (USD MILLION) 69
TABLE 59 MALAYSIA: BLOOD COLLECTION MARKET, BY METHOD, 2019–2030 (USD MILLION) 69
TABLE 60 MALAYSIA: BLOOD COLLECTION MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 69
TABLE 61 MALAYSIA: BLOOD COLLECTION MARKET, BY END USER, 2019–2030 (USD MILLION) 70
TABLE 62 SOUTH KOREA: BLOOD COLLECTION MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 70
TABLE 63 SOUTH KOREA: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY FORM, 2019–2030 (USD MILLION) 70
TABLE 64 SOUTH KOREA: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY TYPE, 2019–2030 (USD MILLION) 71
TABLE 65 SOUTH KOREA: BLOOD COLLECTION MARKET, BY METHOD, 2019–2030 (USD MILLION) 71
TABLE 66 SOUTH KOREA: BLOOD COLLECTION MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 71
TABLE 67 SOUTH KOREA: BLOOD COLLECTION MARKET, BY END USER, 2019–2030 (USD MILLION) 72
TABLE 68 AUSTRALIA & NEW ZEALAND: BLOOD COLLECTION MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 72
TABLE 69 AUSTRALIA & NEW ZEALAND: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY FORM,
2019–2030 (USD MILLION) 72
TABLE 70 AUSTRALIA & NEW ZEALAND: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY TYPE,
2019–2030 (USD MILLION) 73
TABLE 71 AUSTRALIA & NEW ZEALAND: BLOOD COLLECTION MARKET, BY METHOD, 2019–2030 (USD MILLION) 73
TABLE 72 AUSTRALIA & NEW ZEALAND: BLOOD COLLECTION MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 73
TABLE 73 AUSTRALIA & NEW ZEALAND: BLOOD COLLECTION MARKET, BY END USER, 2019–2030 (USD MILLION) 74
TABLE 74 REST OF ASIA-PACIFIC: BLOOD COLLECTION MARKET, BY PRODUCT, 2019–2030 (USD MILLION) 75
TABLE 75 REST OF ASIA-PACIFIC: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY FORM, 2019–2030 (USD MILLION) 75
TABLE 76 REST OF ASIA-PACIFIC: BLOOD COLLECTION MARKET, FOR BLOOD COLLECTION TUBES, BY TYPE, 2019–2030 (USD MILLION) 76
TABLE 77 REST OF ASIA-PACIFIC: BLOOD COLLECTION MARKET, BY METHOD, 2019–2030 (USD MILLION) 76
TABLE 78 REST OF ASIA-PACIFIC: BLOOD COLLECTION MARKET, BY APPLICATION, 2019–2030 (USD MILLION) 76
TABLE 79 REST OF ASIA-PACIFIC: BLOOD COLLECTION MARKET, BY END USER, 2019–2030 (USD MILLION) 77
TABLE 80 MAJOR PLAYERS IN THE ASIA-PACIFIC BLOOD COLLECTION MARKET 78
TABLE 81 MOST ACTIVE PLAYER IN THE ASIA-PACIFIC BLOOD COLLECTION MARKET 80
TABLE 82 EXPANSION 81
TABLE 83 QUEST DIAGNOSTICS INCORPORATED: PRODUCTS OFFERED 84
TABLE 84 ICU MEDICAL: PRODUCTS OFFERED 89
TABLE 85 KAWASUMI LABORATORIES AMERICA: PRODUCTS OFFERED 91
TABLE 86 HAEMONETICS CORPORATION: PRODUCTS OFFERED 93
TABLE 87 NIPRO MEDICAL CORPORATION: PRODUCTS OFFERED 95
TABLE 88 NIPRO MEDICAL CORPORATION: KEY DEVELOPMENTS 96
TABLE 89 BECTON, DICKINSON, AND COMPANY: PRODUCTS OFFERED 99
TABLE 90 TERUMO MEDICAL CORPORATION: PRODUCTS OFFERED 106
TABLE 91 FRESENIUS KABI AG: PRODUCTS OFFERED 109
TABLE 92 GRIFOLS S.A.: PRODUCTS OFFERED 111